Rosiglitazone, a Ligand to PPAR γ, Improves Blood Pressure and Vascular Function through Renin-Angiotensin System Regulation

PPAR Research

Volumn 2019, Issue , 2019, Pages

  Sánchez Aguilar, María ^a,b   Ibarra Lara, Luz ^a   Del Valle Mondragón, Leonardo ^a   Rubio Ruiz, María Esther ^a   Aguilar Navarro, Alicia G ^b   Zamorano Carrillo, Absalom ^b   Ramírez Ortega, Margarita Del Carmen ^a   Pastelín Hernández, Gustavo ^a   Sánchez Mendoza, Alicia ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; CCAAT ENHANCER BINDING PROTEIN ALPHA; DIPEPTIDYL CARBOXYPEPTIDASE; MALONALDEHYDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE;

ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; AORTIC COARCTATION; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; LIMIT OF QUANTITATION; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SECOND CERVICAL VERTEBRA; SYSTOLIC BLOOD PRESSURE; WESTERN BLOTTING;

EID: 85062348450     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2019/1371758     Document Type: Article

References (44)

1. D. Iusuf, R. H. Henning, W. H. van Gilst, and A. J. M. Roks, "Angiotensin-(1-7): pharmacological properties and pharmacotherapeutic perspectives, " European Journal of Pharmacology, vol. 585, no. 2-3, pp. 303-312, 2008.
2. B. S. VanThiel, I. Van Der Pluijm, L. Te Riet, J. Essers, and A. H. J. Danser, "Therenin-angiotensin system and its involvement in vascular disease, " European Journal of Pharmacology, vol. 763, pp. 3-14, 2015.
3. J. L. Wilson, R. Duan, A. El-Marakby, A. Alhashim, and D. L. Lee, "Peroxisome proliferator activated receptor- agonist slows the progression of hypertension, attenuates plasma interleukin-6 levels and renal inflammatory markers in angiotensin II infused mice, " PPAR Research, vol. 2012, Article ID 645969, 7 pages, 2012.
4. A. Aranda and A. Pascual, "Nuclear hormone receptors and gene expression, " Physiological Reviews, vol. 81, no. 3, pp. 1269-1304, 2001.
5. J. D. Brown and J. Plutzky, "Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets, " Circulation, vol. 115, no. 4, pp. 518-533, 2007.
6. V. Costa, D. Foti, F. Paonessa et al., "The insulin receptor: A new anticancer target for peroxisome proliferator-activated receptor-γ (PPARγ) and thiazolidinedione- PPARγ agonists, " Endocrine-Related Cancer, vol. 15, no. 1, pp. 325-335, 2008.
7. I. Barroso, M. Gurnell, V. E. F. Crowley et al., "Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension, " Nature, vol. 402, no. 6764, pp. 880-883, 1999.
8. M. J. Ryan, S. P. Didion, S. Mathur, F. M. Faraci, and C. D. Sigmund, "PPARγ agonist rosiglitazone improves vascular function and lowers blood pressure in hypertensive transgenic mice, " Hypertension, vol. 43, no. 3, pp. 661-666, 2004.
9. J. Song, M. A. Knepper, X. Hu, J. G. Verbalis, and C. A. Ecelbarger, "Rosiglitazone activates renal sodium- and waterreabsorptive pathways and lowers blood pressure in normal rats, "The Journal of Pharmacology and ExperimentalTherapeutics, vol. 308, no. 2, pp. 426-433, 2004.
10. K. Takeda, T. Ichiki, T. Tokunou et al., "Peroxisome proliferatoractivated receptor γ activators downregulate angiotensin II type 1 receptor in vascular smoothmuscle cells, " Circulation, vol. 102, no. 15, pp. 1834-1839, 2000.
11. M.Fernandes, G. Onesti, A.Weder, R. Dykyj, A. B. Gould, K. E. Kim et al., "Experimental model of severe renal hypertension, " The Journal of Laboratory and Clinical Medicine, vol. 87, no. 4, pp. 561-567, 1976.
12. A. Sánchez-Mendoza, E. Hong, and B. Escalante, "The role of nitric oxide in angiotensin II-induced renal vasoconstriction in renovascular hypertension, " Journal of Hypertension, vol. 16, no. 5, pp. 697-703, 1998.
13. M. E. Rubio, G. Baños, E. Díaz, and V. Guarner, "Effect of age on insulin-induced endothelin release and vasoreactivity in hypertriglyceridemic and hypertensive rats, " Experimental Gerontology, vol. 41, no. 3, pp. 282-288, 2006.
14. E. Chiefari, F. Paonessa, S. Iiritano et al., "The cAMP-HMGA1-RBP4 system: A novel biochemical pathway for modulating glucose homeostasis, " BMC Biology, vol. 7, p. 24, 2009.
15. L. Ibarra-Lara, L. G. Cervantes-Pérez, F. Pérez-Severiano et al., "PPARα stimulation exerts a blood pressure lowering effect through different mechanisms in a time-dependent manner, " European Journal of Pharmacology, vol. 627, no. 1-3, pp. 185-193, 2010.
16. F. A. Tenorio-López, G. Zarco-Olvera, A. Sánchez-Mendoza, M. Rosas-Peralta, G. Pastelín-Hernández, and L. del Valle-Mondragón, "Simultaneous determination of angiotensins II and 1-7 by capillary zone electrophoresis in plasma and urine from hypertensive rats, " Talanta, vol. 80, no. 5, pp. 1702-1712, 2010.
17. K. Claeson, F. Åberg, and B. Karlberg, "Free malondialdehyde determination in rat brain tissue by capillary zone electrophoresis: Evaluation of two protein removal procedures, " Journal of Chromatography B: Biomedical Sciences and Applications, vol. 740, no. 1, pp. 87-92, 2000.
18. V. Kvasnicová, E. Samcová, A. Jursová, and I. Jelínek, "Determination of 8-hydroxy-2′-deoxyguanosine in untreated urine by capillary electrophoresis with UV detection, " Journal of Chromatography A, vol. 985, no. 1-2, pp. 513-517, 2003.
19. R. Apak, K. Güçlü, M. Özyürek, S. E. Karademir, and M. Altun, "Total antioxidant capacity assay of human serum using copper(II)-neocuproine as chromogenic oxidant: The CUPRACmethod, " Free Radical Research, vol. 39, no. 9, pp. 949-961, 2005.
20. M. Sanchez-Aguilar, L. Ibarra-Lara, B. Zamora-Lopez, A. Sanchez-Mendoza, and A. Zamorano-Carrillo, "Detecting patterns in 5′ untranslated regions of genes involved in the regulation of blood pressure and oxidative stress, " American Medical Journal, vol. 4, no. 2, pp. 184-189, 2013.
21. C. M. Ferrario, M. C. Chappell, E. A. Tallant, K. B. Brosnihan, and D. I. Diz, "Counterregulatoryactions of angiotensin-(1-7), " Hypertension, vol. 30, no. 3, part 2, pp. 535-541, 1997.
22. G. M. Etelvino, A. A. B. Peluso, and R. A. S. Santos, "New components of the renin-angiotensin system: alamandine and theMas-related G protein-coupled receptor D, " Current Hypertension Reports, vol. 16, no. 6, article 433, 2014.
23. Q.N.Diep, M. E.Mabrouk, J. S.Cohnet al., "Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferatoractivated receptor-γ, " Circulation, vol. 105, no. 19, pp. 2296-2302, 2002.
24. L.-Y. Deng and E. L. Schiffrin, "Endothelin-1 gene expression in blood vessels and kidney of Spontaneously Hypertensive Rats (SHR), L-NAME-treated SHR, and renovascular hypertensive rats, " Journal of Cardiovascular Pharmacology, vol. 31, no. 1, pp. S380-S383, 1998.
25. D. Endemann, R. M. Touyz, J.-S. Li, L.-Y. Deng, and E. L. Schiffrin, "Altered angiotensin II-induced small artery contraction during the development of hypertension in spontaneously hypertensive rats, "American Journal ofHypertension, vol. 12, no. 7, pp. 716-723, 1999.
26. R. E. Purdy and M. A. Weber, "Angiotensin II amplification of alpha-adrenergic vasoconstriction: role of receptor reserve, " Circulation Research, vol. 63, no. 4, pp. 748-757, 1988.
27. L. G. Cervantes-Pérez, M. D. L. L. Ibarra-Lara, M. E. Rubio et al., "Effect of clofibrate on vascular reactivity in amodel of high blood pressure secondary to aortic coarctation, " Pharmacological Reports, vol. 62, no. 5, pp. 874-882, 2010.
28. S. Efrati, S. Berman, E. Ilgiyeav, Z. Averbukh, and J.Weissgarten, "PPAR-γ activation inhibits angiotensin II synthesis, apoptosis, and proliferation of mesangial cells from spontaneously hypertensive rats, " Nephron Experimental Nephrology, vol. 106, no. 4, pp. e107-e112, 2007.
29. D. Bishop-Bailey, T. Hla, and T. D. Warner, "Bisphenol A diglycidyl ether (BADGE) is a PPARγ agonist in an ECV304 cell line, " British Journal of Pharmacology, vol. 131, no. 4, pp. 651-654, 2000.
30. R. Chamorro-García, S. Kirchner, X. Li et al., "Bisphenol A diglycidyl ether induces adipogenic differentiation of multipotent stromal stem cells through a peroxisome proliferatoractivated receptor gamma-independent mechanism, " Environmental Health Perspectives, vol. 120, no. 7, pp. 984-989, 2012.
31. A. S. Pupo, D. A.Duarte, V. Lima, L. B.Teixeira, L. T. Parreirase-Silva, and C.M.Costa-Neto, "Recent updates onGPCRbiased agonism, " Pharmacological Research, vol. 112, pp. 49-57, 2016.
32. M. T. Drake, J. D.Violin, E. J.Whalen, J.W.Wisler, S. K. Shenoy, and R. J. Lefkowitz, "Beta-arrestin-biased agonism at the beta2-adrenergic receptor, "The Journal of Biological Chemistry, vol. 283, no. 9, pp. 5669-5676, 2008.
33. L. Spontaneo and N. Cercone, "Correlating CpG islands, motifs, and sequence variants in human chromosome 21, " BMC Genomics, vol. 12, supplement 2, article S10, 2011.
34. M. K. Das and H.-K. Dai, "A survey of DNA motif finding algorithms, " BMC Bioinformatics, vol. 8, supplement 7, article S21, 2007.
35. D. J. Patel, A. T. Phan, and V. Kuryavyi, "Humantelomere, oncogenic promoter and 5′-UTR G-quadruplexes: diverse higher order DNA and RNA targets for cancer therapeutics, " Nucleic Acids Research, vol. 35, no. 22, pp. 7429-7455, 2007.
36. M. Iwashina, Y. Hirata, T. Imai, K. Sato, and F. Marumo, "Molecular cloning of endothelial, inducible nitric oxide synthase gene from rat aortic endothelial cell, " European Journal of Biochemistry, vol. 237, no. 3, pp. 668-673, 1996.
37. Y. Ji and A. V. Tulin, "Post-transcriptional regulation by poly(ADP-ribosyl)ation of the RNA-binding proteins, " International Journal of Molecular Sciences, vol. 14, no. 8, pp. 16168-16183, 2013.
38. J.Ma, R. Wang, X. Fang, Y. Ding, and Z. Sun, "Critical role of TCF-1 in repression of the IL-17 gene, " PLoS ONE, vol. 6, no. 9, Article ID e24768, 2011.
39. F. Luca, J. C. Maranville, A. L. Richards, D. B. Witonsky, M. Stephens, and A. Di Rienzo, "Genetic, functional and molecular features of glucocorticoid receptor binding, " PLoS ONE, vol. 8, no. 4, Article ID e61654, 2013.
40. J. E. Goodwin, J. Zhang, D. Gonzalez, S. Albinsson, and D. S. Geller, "Knockout of the vascular endothelial glucocorticoid receptor abrogates dexamethasone-induced hypertension, " Journal of Hypertension, vol. 29, no. 7, pp. 1347-1356, 2011.
41. H. C. Pan, C.N. Yang, Y.W.Hung et al., "Reciprocalmodulation of C/EBP-α and C/EBP-β by IL-13 in activated microglia prevents neuronal death, " European Journal of Immunology, vol. 43, no. 11, pp. 2854-2865, 2013.
42. E. C. Hart, N. Charkoudian, and V. M. Miller, "Sex, hormones and neuroeffectormechanisms, " Acta Physiologica, vol. 203, no. 1, pp. 155-165, 2011.
43. R. M. Gronostajski, "Roles of the NFI/CTF gene family in transcription and development, " Gene, vol. 249, no. 1-2, pp. 31-45, 2000.
44. A. Jadhav, E. Torlakovic, and J. F. Ndisang, "Interaction among heme oxygenase, nuclear factor-κB, and transcription activating factors in cardiac hypertrophy in hypertension, " Hypertension, vol. 52, no. 5, pp. 910-917, 2008.